Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

COVID-19 Serotherapy MeSH Descriptor Data 2025


MeSH Heading
COVID-19 Serotherapy
Tree Number(s)
E02.095.465.425.400.330.050.200
E05.478.550.520.050.200
Unique ID
D000093522
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000093522
Scope Note
Transfer of blood plasma derived from patients who have recovered from COVID-19 to non-immune hosts.
Entry Term(s)
COVID-19 Convalescent Plasma Treatment
COVID-19 Convalescent Serum Treatment
COVID-19 Hyperimmune Globulin Therapy
COVID-19 Serum Therapy
COVID19 Hyperimmune Globulin Therapy
COVID19 Serotherapy
COVID19 Serum Therapy
Convalescent Plasma Treatment for Covid-19
Convalescent Serum Treatment for Covid-19
Coronavirus Disease 2019 Serotherapy
Coronavirus Disease-19 Serotherapy
Covid-19 Convalescent Sera Treatment
Hyperimmune Globulin Therapy for COVID-19
SARS-CoV-2 Convalescent Plasma Treatment
SARS-CoV-2 Convalescent Sera Treatment
SARS-CoV-2 Convalescent Serum Treatment
Public MeSH Note
2023; COVID-19 SEROTHERAPY was indexed under COVID-19 2020-2022, and IMMUNIZATION, PASSIVE 2020-2022
History Note
2023 (2020)
Date Established
2023/01/01
Date of Entry
2022/07/14
Revision Date
2022/07/14
COVID-19 Serotherapy Preferred
COVID-19 Convalescent Serum Treatment Narrower
COVID-19 Convalescent Plasma Treatment Narrower
COVID-19 Hyperimmune Globulin Therapy Narrower
page delivered in 0.129s